Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration

Molecular Genetics and Metabolism

Volumn 81, Issue 1, 2004, Pages 45-51

  Fiege, Betina ^a,c   Ballhausen, Diana ^a   Kierat, Lucja ^a   Leimbacher, Walter ^a   Goriounov, Dimitri ^a   Schircks, Bernhard ^b   Thöny, Beat ^a   Blau, Nenad ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Schircks Laboratories   (Switzerland)

^c SAN PAOLO HOSPITAL   (Italy)

Author keywords

Biopterin; Endothelial dysfunction; Hyperphenylalaninemia; NOS; PKU

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DITHIOERYTHRITOL; TETRAHYDROBIOPTERIN;

ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OXIDATION; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; LOADING TEST; MALE; NORMAL HUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TREATMENT INDICATION;

EID: 0347086140     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.09.014     Document Type: Article

References (27)

1. Thöny B., Auerbach G., Blau N. Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem. J. 347:2000;1-26.
2. Blau N., Thöny B., Cotton R.G.H., Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Vogelstein B. The Metabolic and Molecular Bases of Inherited Disease. eighth ed. 2001;1725-1776 McGraw-Hill, New York.
3. Kure S., Hou D.C., Ohura T., Iwamoto H., Suzuki S., Sugiyama N., Sakamoto O., Fujii K., Matsubara Y., Narisawa K. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 135(3):1999;375-378.
4. Trefz F.K., Aulela-Scholz C., Blau N. Successful treatment of phenylketonuria with tetrahydrobiopterin. Eur. J. Pediatr. 160:2001;315.
5. Niederwieser A., Curtius H.C., Wang M., Leupold D. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur. J. Pediatr. 138(2):1982;110-112.
6. Andersson D.N., Abousaleh M.T., Collins J., Hughes K., Cattell R.J., Hamon C.G.B., Blair J.A., Dewey M.E. Pterin metabolism in depression - An extension of the amine hypothesis and possible marker of response to ECT. Psychol. Med. 22:1992;863-869.
7. Fernell E., Watanabe Y., Adolfsson I., Tani Y., Bergström M., Hartvig P., Lilja A., von Knorring A., Gillberg C., Langström B. Possible effect of tetrahydrobiopterin treatment in six children with autism-clinical and positron emission tomography data: a pilot study. Develop. Med. Child Neurol. 39:1997;313-318.
8. Curtius H.C., Niederwieser A., Levine R., Muldner H. Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease. Adv. Neurol. 40:1984;463-466.
9. Barford P.A., Blair J.A., Eggar C., Hamon C., Morar C., Whitburn S.B. Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J. Neurol. Neurosurg. Psychiatry. 47:1984;736-738.
10. Cosentino F., Luscher T.F. Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc. Res. 43(2):1999;274-278.
11. Ponzone A., Guardamagna O., Ferraris S., Ferrero G.B., Dianzani I., Cotton R.G.H. Tetrahydrobiopterin loading test in hyperphenylalaninemia. Pediatr. Res. 30:1991;435-438.
12. Bernegger C., Blau N. High frequency of tetrahydrobiopterin- responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002. Mol. Genet. Metab. 77:2002;304-313.
13. Fukushima T., Nixon J.C. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal. Biochem. 102:1980;176-188.
14. Curtius H.C., Blau N., Kuster T. Pterins. Hommes F.A. Techniques in Diagnostic Human Biochemical Genetics. 1991;377-396 Wiley-Liss, New York.
15. N. Blau, B. Fiege, F.K. Trefz, Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: diagnosis, treatment, genetics, and international BIOPKU database, in: N. Blau, B. Thöny (Eds.), Pterins, Folates, and Neurotransmitters in Molecular Medicine, SPS Publications, Heilbronn, 2003 (in press).
16. Bonafe L., Blau N., Burlina A.P., Romstad A., Guttler F., Burlina A.B. Treatable neurotransmitter deficiency in mild phenylketonuria. Neurology. 57:2001;908-910.
17. Koch R., Guttler F., Blau N. Mental illness in mild PKU responds to biopterin. Mol. Genet. Metab. 75(3):2002;284-286.
18. Tiefenbacher C.P. Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am. J. Physiol. Heart Circ. Physiol. 280(6):2001;H2484-2488.
19. Katusic Z.S. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am. J. Physiol. Heart Circ. Physiol. 281(3):2001;H981-986.
20. Yamashiro S., Kuniyoshi Y., Arakaki K., Miyagi K., Koja K. The effect of insufficiency of tetrahydrobiopterin on endothelial function and vasoactivity. Jpn. J. Thorac. Cardiovasc. Surg. 50(11):2002;472-477.
21. Blau N., Thöny B., Vasquez-Vivar J., Rajagopalan S. Possible impact of tetrahydrobiopterin and sepiapterin on endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 23:2003;913-915.
22. ′ -deoxysepialumazine J. Chromatogr. 290:1984;303-310.
23. Niederwieser A., Matasovic A., Kuster T., Staudenmann W., Pfleiderer W., Scheibenreiter S. Catabolism of tetrahydrobiopterin in man. Cooper B.A., Whitehead V.M. Chemistry and Biology of Pteridines. 1986;Walter de Gruyter, Berlin.
24. 14C]tetrahydrobiopterin and its developmental change in mice. J. Pharmacol. Exp. Ther. 267(2):1993;971-978.
25. Hayashi T., Ogata A., Takehisha M., Komoridani K., Oonuma N. Studies on metabolism and disposition of sapropterine hydrochloride (SUN-0588) L-erythro-tetrahydrobiopterin dichloride in rats. Clin. Report. 26:1992;3471-3495.
26. Podjarny E., Benchetrit S., Rathaus M., Pomeranz A., Rashid G., Shapira J., Bernheim J. Effect of tetrahydrobiopterin on blood pressure in rats after subtotal nephrectomy. Nephron Physiol. 94(1):2003;P6-9.
27. Mitchell B.M., Dorrance A.M., Webb R.C. GTP cyclohydrolase I downregulation contributes to glucocorticoid hypertension in rats. Hypertension. 41(3 Pt 2):2003;669-674.